Case number 2023-1395
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 14, 2024 | 0 | REGENERON PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS INC. [ORDER] [nonprecedential] (0) |
| Jul 9, 2024 | 61 | ORDER dismissing Appeal No 23-1395 pursuant to FRAP 42(b); issuing mandate. Service as of this date by the Clerk of Court. [1016315] [23-1395, 23-1396] [MVH] [Entered: 07/09/2024 11:25 AM] (1) |
| Jul 8, 2024 | 60 | Joint Stipulation of Voluntary Dismissal for Appellant Regeneron Pharmaceuticals, Inc.. Service: 07/08/2024 by email. [1015899] [23-1395] [Thomas Saunders] [Entered: 07/08/2024 09:46 AM] (2) |
| Jun 4, 2024 | 59 | Response to notice of oral argument from Appellees Mylan Pharmaceuticals Inc., Celltrion, Inc. and Apotex Inc.. Service: 06/04/2024 by email. [1008835] [23-1395] [Deanne Mazzochi] [Entered: 06/04/2024 07:18 PM] (1) |
| May 31, 2024 | 58 | Response to notice of oral argument from Appellant Regeneron Pharmaceuticals, Inc.. Service: 05/31/2024 by email. [1007828] [23-1395] [Thomas Saunders] [Entered: 05/31/2024 12:18 PM] (1) |
| May 21, 2024 | 57 | NOTICE OF ORAL ARGUMENT. Panel: 2407H. Case scheduled July 12, 2024. Response to Notice of Oral Argument due: 06/04/2024. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1005671] [MJL] [Entered: 05/21/2024 04:10 PM] (2) |
| Jan 2, 2024 | 56 | Notice from Appellant Regeneron Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 01/02/2024 by email. [974003] [23-1395] [Thomas Saunders] [Entered: 01/02/2024 01:02 PM] (4) |
| Dec 21, 2023 | 55 | **TEXT ONLY** ORDER granting motion to withdraw attorney [54] filed by Appellee Apotex Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [972013] [JSP] [Entered: 12/21/2023 09:56 AM] (0) |
| Dec 20, 2023 | 54 | MOTION of Appellee Apotex Inc. to withdraw counsel Teresa Stanek Rea. Service: 12/20/2023 by email. [971967] [23-1395] [Teresa Rea] [Entered: 12/20/2023 09:12 PM] (7) |
| Dec 20, 2023 | 53 | Amended Entry of Appearance for Deborah H. Yellin; Shannon M. Lentz as counsel for Appellee Apotex Inc.. Service: 12/20/2023 by email. [971966] [23-1395] [Deborah Yellin] [Entered: 12/20/2023 09:07 PM] (1) |
| Nov 30, 2023 | 52 | Entry of Appearance for Neil B. McLaughlin as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 11/30/2023 by email. [966783] [23-1395] [Neil McLaughlin] [Entered: 11/30/2023 05:45 PM] (1) |
| Nov 28, 2023 | 51 | Notice from Appellee Celltrion, Inc. regarding conflicts with oral argument. Service: 11/28/2023 by email. [966094] [23-1395] [Lora Green] [Entered: 11/28/2023 11:24 PM] (2) |
| Nov 21, 2023 | 50 | Notice to Appellee Celltrion, Inc.: The record of this case indicates that no Response to Notice to Advise of Scheduling Conflicts under FCR 34(d)(2) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [964819] [KMH] [Entered: 11/21/2023 10:38 AM] (0) |
| Nov 16, 2023 | 49 | Notice from Appellant Regeneron Pharmaceuticals, Inc. of Withdrawal of Victoria Reines as Counsel. Service: 11/16/2023 by email. [963721] [23-1395] [Thomas Saunders] [Entered: 11/16/2023 08:43 AM] (2) |
| Nov 3, 2023 | 48 | The following conflict dates submitted by William A. Rakoczy for Mylan Pharmaceuticals Inc. have been accepted by the court: 01/08/2024, 01/09/2024, 01/10/2024, 01/11/2024, 01/12/2024, 06/03/2024, 06/04/2024, 06/05/2024, 06/06/2024, 06/07/2024. [961320] [MJL] [Entered: 11/03/2023 02:20 PM] (0) |
| Nov 3, 2023 | 47 | Notice from Appellee Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 11/03/2023 by email. [961240] [23-1395] [William Rakoczy] [Entered: 11/03/2023 01:07 PM] (5) |
| Nov 3, 2023 | 46 | Notice from Appellee Apotex Inc. regarding conflicts with oral argument. Service: 11/03/2023 by email. [961225] [23-1395] [Shannon Lentz] [Entered: 11/03/2023 12:48 PM] (2) |
| Oct 31, 2023 | 45 | 6 paper copies of Doc. No. [31] received from Appellees Apotex Inc., Celltrion, Inc. and Mylan Pharmaceuticals Inc.. [960321] [VDW] [Entered: 10/31/2023 12:01 PM] (0) |
| Oct 31, 2023 | 44 | 6 paper copies of Doc. No. [36], [35], [26] received from Appellant Regeneron Pharmaceuticals, Inc.. [960319] [VDW] [Entered: 10/31/2023 11:59 AM] (0) |
| Oct 31, 2023 | 43 | The following conflict dates submitted by Thomas Saunders for Regeneron Pharmaceuticals, Inc. have been accepted by the court: 03/04/2024, 03/05/2024, 03/06/2024, 03/07/2024, 03/08/2024. [960312] [MJL] [Entered: 10/31/2023 11:53 AM] (0) |
| Oct 30, 2023 | 42 | Notice from Appellant Regeneron Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 10/30/2023 by email. [960038] [23-1395] [Thomas Saunders] [Entered: 10/30/2023 02:00 PM] (4) |
| Oct 27, 2023 | 41 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [959780] [KMH] [Entered: 10/27/2023 03:51 PM] (0) |
| Oct 27, 2023 | 40 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [959779] [KMH] [Entered: 10/27/2023 03:49 PM] (1) |
| Oct 20, 2023 | 39 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Mylan Pharmaceuticals Inc.. Service: 10/20/2023 by email. [958066] [23-1395] [William Rakoczy] [Entered: 10/20/2023 05:47 PM] (5) |
| Oct 20, 2023 | 38 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Regeneron Pharmaceuticals, Inc.. Service: 10/20/2023 by email. [957812] [23-1395] [Thomas Saunders] [Entered: 10/20/2023 10:37 AM] (5) |
| Oct 20, 2023 | 37 | MODIFIED ENTRY: APPENDIX FILED by Appellant Regeneron Pharmaceuticals, Inc.. Service: 10/20/2023 by email. [957811] --[Edited 10/27/2023 by KMH - compliance review complete] [Thomas Saunders] [Entered: 10/20/2023 10:31 AM] (1536) |
| Oct 20, 2023 | 36 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Regeneron Pharmaceuticals, Inc.. Service: 10/20/2023 by email. [957809]--[Edited 10/27/2023 by KMH - compliance review complete] [Thomas Saunders] [Entered: 10/20/2023 10:27 AM] (0) |
| Oct 13, 2023 | 35 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Regeneron Pharmaceuticals, Inc.. Service: 10/13/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [956240] --[Edited 10/20/2023 by KMH - compliance review complete] [Thomas Saunders] [Entered: 10/13/2023 01:01 PM] (42) |
| Oct 13, 2023 | 34 | Notice of Related Case Information for Appellant Regeneron Pharmaceuticals, Inc.. Service: 10/13/2023 by email. [956239] [23-1395] [Thomas Saunders] [Entered: 10/13/2023 12:59 PM] (3) |
| Sep 12, 2023 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file brief [32] filed by Appellant Regeneron Pharmaceuticals, Inc. The reply brief is due 10/13/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [949420] [MMA] [Entered: 09/12/2023 12:05 PM] (0) |
| Sep 8, 2023 | 32 | MOTION of Appellant Regeneron Pharmaceuticals, Inc. to extend the time to 10/13/2023 to file brief. Service: 09/08/2023 by email. [948802] [23-1395] [Thomas Saunders] [Entered: 09/08/2023 03:07 PM] (7) |
| Sep 1, 2023 | 31 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Apotex Inc., Celltrion, Inc. and Mylan Pharmaceuticals Inc. Service: 09/01/2023 by email. [947468]--[Edited 09/12/2023 by MMA - Reason: compliance review complete] [Deanne Mazzochi] [Entered: 09/01/2023 04:54 PM] (97) |
| Jul 27, 2023 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Appellee Mylan Pharmaceuticals Inc. The response briefs are due 09/01/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [938990] [ALK] [Entered: 07/27/2023 04:23 PM] (0) |
| Jul 11, 2023 | 29 | MOTION of Appellee Mylan Pharmaceuticals Inc. to extend the time to 09/01/2023 to file brief. Service: 07/11/2023 by email. [935587] [23-1395] [Eric Hunt] [Entered: 07/11/2023 10:20 PM] (11) |
| Jun 9, 2023 | 28 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellee Mylan Pharmaceuticals Inc. The response brief is due 08/02/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [928942] [KMH] [Entered: 06/09/2023 10:43 AM] (0) |
| Jun 5, 2023 | 27 | MOTION of Appellee Mylan Pharmaceuticals Inc. to extend the time to 08/02/2023 to file brief. Service: 06/05/2023 by email. [927735] [23-1395] [Lauren Lesko] [Entered: 06/05/2023 02:10 PM] (10) |
| May 24, 2023 | 26 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Regeneron Pharmaceuticals, Inc.. Service: 05/24/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [925658] --[Edited 06/02/2023 by KMH - compliance review complete] [Thomas Saunders] [Entered: 05/24/2023 02:20 PM] (250) |
| May 24, 2023 | 25 | Notice of Related Case Information for Appellant Regeneron Pharmaceuticals, Inc.. Service: 05/24/2023 by email. [925653] [23-1395] [Thomas Saunders] [Entered: 05/24/2023 02:17 PM] (3) |
| May 24, 2023 | 24 | Amended Certificate of Interest for Appellant Regeneron Pharmaceuticals, Inc.. Service: 05/24/2023 by email. [925652] [23-1395] [Thomas Saunders] [Entered: 05/24/2023 02:16 PM] (3) |
| Apr 11, 2023 | 23 | Notice of Related Case Information for Appellee Mylan Pharmaceuticals Inc.. Service: 04/11/2023 by email. [915816] [23-1395] [William Rakoczy] [Entered: 04/11/2023 12:20 AM] (3) |
| Apr 11, 2023 | 22 | Amended Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 04/11/2023 by email. [915815] [23-1395] [William Rakoczy] [Entered: 04/11/2023 12:18 AM] (3) |
| Mar 29, 2023 | 21 | **TEXT ONLY** ORDER granting motion to extend time to file brief [20] filed by Appellant Regeneron Pharmaceuticals, Inc.. The opening brief is due 05/24/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [913144] [KMH] [Entered: 03/29/2023 04:48 PM] (0) |
| Mar 27, 2023 | 20 | MOTION of Appellant Regeneron Pharmaceuticals, Inc. to extend the time to 05/24/2023 to file brief. Service: 03/27/2023 by email. [912310] [23-1395] [Thomas Saunders] [Entered: 03/27/2023 09:35 AM] (8) |
| Feb 28, 2023 | 19 | Certified list received. Service: 02/22/2023 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [906731] [23-1395, 23-1396] [KMH] [Entered: 02/28/2023 10:10 AM] (163) |
| Feb 6, 2023 | 18 | Note to File: The following cases are consolidated: 23-1395 Lead with 23-1396 Member Case. The parties must file all documents in the lead appeal only. [902237] [23-1395, 23-1396] [CMH] [Entered: 02/06/2023 03:47 PM] (0) |
| Feb 6, 2023 | 17 | ORDER consolidating appeals 23-1395 and 23-1396. The Certified Lists are due no later than 02/22/2023. Service as of this date by the Clerk of Court. [902220] [23-1395, 23-1396] [CMH] [Entered: 02/06/2023 03:40 PM] (2) |
| Feb 6, 2023 | 16 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Celltrion, Inc., Amended Entry of Appearance [15], is not in compliance with the rules of this court (see attached). Compliant document is due on 02/13/2023. Service as of this date by the Clerk of Court. [902198] [CMH] [Entered: 02/06/2023 03:24 PM] (1) |
| Feb 3, 2023 | 15 | Amended Entry of Appearance for Lora M. Green; Robert Cerwinski; Aviv Zalcenstein; Brigid Morris as counsel for Appellee Celltrion, Inc. Lora M. Green; Robert Cerwinski; Aviv Zalcenstein; Brigid Morris. Service: 02/03/2023 by email. This document is non-compliant. See doc no. [16] [901784] [23-1395] [Lora Green] [Entered: 02/03/2023 12:02 PM] (2) |
| Feb 1, 2023 | 14 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Celltrion, Inc., Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 02/08/2023. Service as of this date by the Clerk of Court. [901357] [CMH] [Entered: 02/01/2023 03:38 PM] (1) |
| Jan 27, 2023 | 13 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 01/27/2023 by email. [900348] [23-1395] [William Rakoczy] [Entered: 01/27/2023 04:36 PM] (2) |
| Jan 27, 2023 | 12 | Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 01/27/2023 by email. [900347] [23-1395] [William Rakoczy] [Entered: 01/27/2023 04:34 PM] (3) |
| Jan 27, 2023 | 11 | Entry of Appearance for William A. Rakoczy; Heinz J. Salmen; Paul J. Molino; Deanne M. Mazzochi; Eric R. Hunt; Lauren M. Lesko; Jeffrey A. Marx as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 01/27/2023 by email. [900342] [23-1395] [William Rakoczy] [Entered: 01/27/2023 04:27 PM] (2) |
| Jan 27, 2023 | 10 | Docketing Statement for the Appellee Celltrion, Inc.. Service: 01/27/2023 by email. [900291] [23-1395] [Lora Green] [Entered: 01/27/2023 03:12 PM] (2) |
| Jan 27, 2023 | 9 | Certificate of Interest for Appellee Celltrion, Inc.. Service: 01/27/2023 by email. [900289] [23-1395] [Lora Green] [Entered: 01/27/2023 03:11 PM] (3) |
| Jan 27, 2023 | 8 | Entry of Appearance for Lora M. Green; Robert Cerwinski; Aviv Zalcenstein; Brigid Morris as counsel for Appellee Celltrion, Inc.. Service: 01/27/2023 by email. This document is non-compliant. See doc no. [14] [900286] [23-1395] [Lora Green] [Entered: 01/27/2023 03:10 PM] (2) |
| Jan 27, 2023 | 7 | Docketing Statement for the Appellee Apotex Inc.. Service: 01/27/2023 by email. [900272] [23-1395] [Teresa Rea] [Entered: 01/27/2023 02:46 PM] (2) |
| Jan 27, 2023 | 6 | Certificate of Interest for Appellee Apotex Inc.. Service: 01/27/2023 by email. [900270] [23-1395] [Teresa Rea] [Entered: 01/27/2023 02:44 PM] (3) |
| Jan 27, 2023 | 5 | Entry of Appearance for Teresa Stanek Rea; Deborah H. Yellin; Shannon M. Lentz as counsel for Appellee Apotex Inc.. Service: 01/27/2023 by email. [900268] [23-1395] [Teresa Rea] [Entered: 01/27/2023 02:42 PM] (2) |
| Jan 27, 2023 | 4 | Docketing Statement for the Appellant Regeneron Pharmaceuticals, Inc.. Service: 01/27/2023 by email. [900095] [23-1395] [Thomas Saunders] [Entered: 01/27/2023 10:04 AM] (2) |
| Jan 27, 2023 | 3 | Certificate of Interest for Appellant Regeneron Pharmaceuticals, Inc.. Service: 01/27/2023 by email. [900094] [23-1395] [Thomas Saunders] [Entered: 01/27/2023 10:03 AM] (3) |
| Jan 27, 2023 | 2 | Entry of Appearance for Thomas G. Saunders; Lauren Matlock-Colangelo; Deborah E. Fishman; Daniel L. Reisner; Abigail Struthers; Victoria L. Reines as counsel for Appellant Regeneron Pharmaceuticals, Inc.. Service: 01/27/2023 by email. [900093] [23-1395] [Thomas Saunders] [Entered: 01/27/2023 10:02 AM] (2) |
| Jan 13, 2023 | 1 | Appeal docketed. Received: 01/10/2023. [896967] Entry of Appearance due 01/27/2023. Certificate of Interest is due on 01/27/2023. Docketing Statement due 01/27/2023. Certified List due on 02/22/2023. [KMH] [Entered: 01/13/2023 03:12 PM] (0) |
